FINDELL CAPITAL MANAGEMENT LLC
Position in MLYS — Mineralys Therapeutics, Inc.
CIK 1814465
New York, NY
Position in MLYS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,472,180
+$3,657,680 QoQ
Shares Held
202,000
+304.0% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
1.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FINDELL CAPITAL MANAGEMENT LLC holds $24,653,100 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
185,000 | $24,653,100 |
All Filings in MLYS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,472,180 | 202,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,814,500 | 50,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,480,000 | 250,000 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $6,352,000 | 400,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||